Finance Powered by Trendolizer

“Is curing patients a sustainable business model?” Goldman Sachs analysts ask

Trending story found on arstechnica.com
“Is curing patients a sustainable business model?” Goldman Sachs analysts ask
Analyst report notes that Gilead’s hep C cure will make less than $4 billion this year.
[Source: arstechnica.com] [ Comments ] [See why this is trending]

Trend graph:

Comments